Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) EPS (Basic)

: $0.59 (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

Aspen Pharmacare Holdings's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was $0.28. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.59.

Aspen Pharmacare Holdings's EPS (Diluted) for the six months ended in Dec. 2023 was $0.28. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.59.

Aspen Pharmacare Holdings's EPS without NRI for the six months ended in Dec. 2023 was $0.37. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 0.81.

During the past 12 months, Aspen Pharmacare Holdings's average EPS without NRIGrowth Rate was 1.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 7.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 1.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Aspen Pharmacare Holdings's highest 3-Year average EPS without NRI Growth Rate was 365.50% per year. The lowest was -6.50% per year. And the median was 22.60% per year.

Aspen Pharmacare Holdings EPS (Basic) Historical Data

The historical data trend for Aspen Pharmacare Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EPS (Basic)

Get a 7-Day Free Trial

0.97

0.60

0.76

0.91

0.63

Aspen Pharmacare Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															0.46	0.44	0.35	0.31	0.28

Aspen Pharmacare Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Aspen Pharmacare Holdings's Basic EPS for the fiscal year that ended in Jun. 2023 is calculated as

Basic EPS (A: Jun. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(278.904	-	0)	/	444.200
	=	0.63

Aspen Pharmacare Holdings's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(124.19	-	0)	/	444.300
	=	0.28

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.59

Aspen Pharmacare Holdings (OTCPK:APNHY) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Aspen Pharmacare Holdings EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

APN:South Africa

Address

Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF

Website

https://www.aspenpharma.com

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Aspiring for Aspen Pharmacare Holdings Ltd's Dividend: A Comprehensive Analysis

By GuruFocus Research • 09-21-2023

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos • 03-17-2019